IL18 and neoplasm: The adoptive transfer of murine splenic NK cells pretreated with IL-12, IL-15, and IL-18, but not naïve or IL-15- or IL-2-pretreated NK cells, into tumor-bearing mice effectively reduced tumor growth, than that of when combined with radiation therapy (94).